Janux Therapeutics Executives Sell Shares for $13.73 Each

Janux Therapeutics, Inc. (JANX) reports that its Director, President, and CEO, Campbell David Alan, has sold 8,072 shares at a price of $13.73 per share on January 2, 2026. Additionally, Chief Scientific Officer DiRaimondo Thomas sold 2,505 shares at the same price, Vice President of Accounting Dobek Maria sold 1,462 shares, Chief Medical Officer McIver Zachariah sold 2,714 shares, and Chief Technical Officer Winter Charles M. sold 2,401 shares.